BioSpace News Archive

Drug Development

The Medicines Company Announces Recommendation by Independent Data Monitoring Committee to Continue Inclisiran Phase III Trials Following Fourth Review of Unblinded Data

More than 1,899 patient-years of safety data accumulated to date – a five-fold increase over total patient exposure through Phase II trials

October 1, 2018
·
4 min read
Biotech Bay

PROCEPT® BioRobotics’ Aquablation Therapy Expands Global Market Access with NICE Guidance and NTAP Incremental Payment

Enhanced Guidance and Incremental Reimbursement Will Strengthen Continued Global Growth of Aquablation® Therapy for the Treatment for Benign Prostatic Hyperplasia

October 1, 2018
·
3 min read
Drug Development

AVEO Oncology Announces Initiation of Topline Analysis of Phase 3 TIVO-3 Trial

Analysis Initiated on the Unanimous Recommendation of the TIVO-3 Study Independent Steering Committee

October 1, 2018
·
9 min read
Business

Appili Therapeutics Appoints Veteran Drug Development Executive, Dr. Armand Balboni, as Its Inaugural Chief Scientific Officer

Appili Therapeutics Inc. has named Dr. Armand Balboni as its first Chief Scientific Officer (CSO).

October 1, 2018
·
4 min read
Lone Star Bio

Le-Vel Kicks Off Month-Long Campaign To Support Breast Cancer Research

Company Continues Commitment to Breast Cancer Awareness

October 1, 2018
·
3 min read
Drug Development

Ocugen Initiates Phase 3 Clinical Trial of OCU310 for Dry Eye Disease

Ocugen, Inc. today announced that it has initiated a Phase 3 clinical trial for its second lead product candidate, OCU310 for patients with dry eye disease (DED).

October 1, 2018
·
3 min read
Business

The National Cancer Institute (NCI) Demonstrates Anti-Cancer Efficacy and Safety of Gibson’s Novel Class of Indenoisoquinolines in Advanced Canine Lymphoma

Gibson Oncology, LLC announced today that the National Cancer Institute (NCI) reported study results from an extensive multi-center canine study using Gibson’s Indenoisoquinolines (LMP400, LMP766, and LMP744) to treat 84 dogs with advanced stages of lymphoma.

October 1, 2018
·
2 min read
Business

Celgene Corporation to Announce Third Quarter 2018 Results on October 25, 2018

Celgene Corporation will host a conference call and live audio webcast on Thursday, October 25, 2018 at 9 a.m. ET to discuss third quarter 2018 financial and operational results.

October 1, 2018
·
1 min read
Business

Manitex Capital Inc. Announces That Its Affiliate Valeo Pharma Inc. Has Filed a Non-Offering Preliminary Prospectus

Manitex Capital Inc. is pleased to announce that its affiliate, Valeo Pharma Inc., has filed a non-offering preliminary prospectus with the securities regulatory authorities of all provinces and territories in Canada.

October 1, 2018
·
2 min read
Policy

Health Canada approves TRESIBA® for children with Type 1 diabetes

Rates of Type 1 diabetes among children and youth on the rise globally

October 1, 2018
·
4 min read